Oregon State University pharmacy professor Daniel Hartung has long suspected that corporate greed is behind skyrocketing prescription drug costs, not pharmaceutical companies' investment in research as company executives regularly claim. Now, Hartung ...
from Google Alert - health https://ift.tt/2XKR0lX
via IFTTT
0 comments:
Post a Comment